scholarly article | Q13442814 |
P50 | author | Kristin M French | Q47502355 |
P2093 | author name string | Michael E Davis | |
Milton E Brown | |||
Joshua T Maxwell | |||
Charles D Searles | |||
Warren D Gray | |||
Manu O Platt | |||
Shohini Ghosh-Choudhary | |||
P2860 | cites work | A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis | Q21135329 |
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line | Q21136096 | ||
Modulation of gene expression by hypoxia in human umbilical cord vein endothelial cells: A transcriptomic and proteomic study | Q24294853 | ||
Metabolic adaptation to a disruption in oxygen supply during myocardial ischemia and reperfusion is underpinned by temporal and quantitative changes in the cardiac proteome | Q39392907 | ||
Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice | Q39508688 | ||
Exosomes as critical agents of cardiac regeneration triggered by cell therapy. | Q40477633 | ||
Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells | Q41836901 | ||
Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). | Q41875540 | ||
Emerging roles of exosomes in neuron-glia communication | Q42139956 | ||
Multipathway kinase signatures of multipotent stromal cells are predictive for osteogenic differentiation: tissue-specific stem cells | Q42374637 | ||
Induced release of membrane vesicles from rat adipocytes containing glycosylphosphatidylinositol-anchored microdomain and lipid droplet signalling proteins | Q46245778 | ||
Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. | Q50613492 | ||
Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. | Q51345347 | ||
Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells | Q24300024 | ||
Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity | Q24321699 | ||
Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes | Q24604279 | ||
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers | Q24614672 | ||
MicroRNA-210 as a novel therapy for treatment of ischemic heart disease | Q24633429 | ||
miRiad roles for the miR-17-92 cluster in development and disease | Q24646970 | ||
Connective tissue growth factor (CCN2, CTGF) and organ fibrosis: lessons from transgenic animals | Q24648246 | ||
The microRNA.org resource: targets and expression | Q24650094 | ||
MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20 | Q24651483 | ||
Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? | Q26992023 | ||
Role of microRNAs in the reperfused myocardium towards post-infarct remodelling | Q27000076 | ||
Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) | Q28216990 | ||
De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures | Q28277249 | ||
CCN2 is required for bleomycin‐induced skin fibrosis in mice | Q28295283 | ||
Heart disease and stroke statistics--2014 update: a report from the American Heart Association | Q29547691 | ||
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma | Q29547772 | ||
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins | Q29615034 | ||
TGF-beta signaling and the fibrotic response | Q29620099 | ||
Adult cardiac stem cells are multipotent and support myocardial regeneration | Q29620122 | ||
Paracrine mechanisms in adult stem cell signaling and therapy | Q29620571 | ||
Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function | Q33863225 | ||
Small molecule inhibition of RISC loading | Q34057371 | ||
Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage | Q34189929 | ||
Cardiac plasticity | Q34764732 | ||
MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats | Q34873256 | ||
Extracellular/circulating microRNAs and their potential role in cardiovascular disease. | Q35513779 | ||
Ultrastructural evidence of exosome secretion by progenitor cells in adult mouse myocardium and adult human cardiospheres | Q36438947 | ||
Patient specific proteolytic activity of monocyte-derived macrophages and osteoclasts predicted with temporal kinase activation states during differentiation. | Q36453271 | ||
MicroRNA-15a and microRNA-16 impair human circulating proangiogenic cell functions and are increased in the proangiogenic cells and serum of patients with critical limb ischemia | Q36739746 | ||
Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application | Q36877313 | ||
Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury. | Q37066520 | ||
Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression | Q37372976 | ||
Intercellular communication: diverse structures for exchange of genetic information | Q38003288 | ||
Exosomes and cardiac repair after myocardial infarction | Q38179329 | ||
P433 | issue | 2 | |
P921 | main subject | hypoxia | Q105688 |
microRNA | Q310899 | ||
systems biology | Q815297 | ||
P304 | page(s) | 255-263 | |
P577 | publication date | 2014-10-24 | |
P1433 | published in | Circulation Research | Q2599020 |
P1476 | title | Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology | |
P478 | volume | 116 |
Q58085908 | A Bioprinted Cardiac Patch Composed of Cardiac-Specific Extracellular Matrix and Progenitor Cells for Heart Repair |
Q91695940 | Adult human cardiac stem cell supplementation effectively increases contractile function and maturation in human engineered cardiac tissues |
Q98159664 | Advances in Exosomes Derived from Different Cell Sources and Cardiovascular Diseases |
Q37042629 | Age-Dependent Effect of Pediatric Cardiac Progenitor Cells After Juvenile Heart Failure |
Q36109825 | An accurate, precise method for general labeling of extracellular vesicles |
Q36269172 | An in vitro model for the assessment of stem cell fate following implantation within the infarct microenvironment identifies ISL-1 expression as the strongest predictor of c-Kit(+) cardiac progenitor cells' therapeutic potential |
Q64070184 | Analysis of Effect of in the Treatment of Myocardial Infarction Based on Three-Mode Gene Ontology Network |
Q50797309 | Angiogenic Mechanisms of Human CD34+ Stem Cell Exosomes in the Repair of Ischemic Hindlimb. |
Q64084644 | Anti-fibrotic Effects of Cardiac Progenitor Cells in a 3D-Model of Human Cardiac Fibrosis |
Q89456606 | Applications of extracellular vesicles in tissue regeneration |
Q90562166 | Approaches to therapeutic angiogenesis for ischemic heart disease |
Q59813444 | Archaea Symbiont of Infection May Explain Heart Failure in Chagas Disease |
Q47137765 | Beneficial effects of exosomes secreted by cardiac-derived progenitor cells and other cell types in myocardial ischemia. |
Q48162551 | Biologically active constituents of the secretome of human W8B2+ cardiac stem cells. |
Q26770294 | Cardiac Extracellular Vesicles in Normal and Infarcted Heart |
Q47763392 | Cardiac Progenitor-Cell Derived Exosomes as Cell-Free Therapeutic for Cardiac Repair |
Q37482846 | Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4. |
Q44325515 | Cardiac progenitor cells application in cardiovascular disease. |
Q45948564 | Cardioprotective Actions of TGFβRI Inhibition Through Stimulating Autocrine/Paracrine of Survivin and Inhibiting Wnt in Cardiac Progenitors. |
Q92998218 | Caveolin-1 selectively regulates microRNA sorting into microvesicles after noxious stimuli |
Q92820171 | Characterization of human cardiac mesenchymal stromal cells and their extracellular vesicles comparing with human bone marrow derived mesenchymal stem cells |
Q39390326 | Concise Review: Challenges in Regenerating the Diabetic Heart: A Comprehensive Review |
Q47928658 | Development of next generation cardiovascular therapeutics through bio-assisted nanotechnology. |
Q93083902 | Differences in the cargos and functions of exosomes derived from six cardiac cell types: a systematic review |
Q52353228 | Do platelets promote cardiac recovery post myocardial infarction: Roles beyond occlusive ischemic damage. |
Q47105204 | Dynamic miRNA-mRNA paradigms: New faces of miRNAs |
Q90414843 | Electrical Stimulation of pediatric cardiac-derived c-kit+ progenitor cells improves retention and cardiac function in right ventricular heart failure |
Q37366682 | Electrically Induced Calcium Handling in Cardiac Progenitor Cells |
Q36657651 | Empowering Adult Stem Cells for Myocardial Regeneration V2.0: Success in Small Steps |
Q58116122 | Endothelial cells release cardioprotective exosomes that may contribute to ischaemic preconditioning |
Q92441044 | Engineering Extracellular Vesicles as Nanotherapeutics for Regenerative Medicine |
Q42645358 | Ethanol Induces Enhanced Vascularization Bioactivity of Endothelial Cell-Derived Extracellular Vesicles via Regulation of MicroRNAs and Long Non-Coding RNAs |
Q57794663 | Evaluation of the cardioprotective potential of extracellular vesicles - a systematic review and meta-analysis |
Q55497478 | Examining the Paracrine Effects of Exosomes in Cardiovascular Disease and Repair. |
Q38836140 | Exosomal MicroRNA Transfer Into Macrophages Mediates Cellular Postconditioning. |
Q96132624 | Exosomal lncRNA AK139128 Derived from Hypoxic Cardiomyocytes Promotes Apoptosis and Inhibits Cell Proliferation in Cardiac Fibroblasts |
Q38667736 | Exosomal miRNAs in Heart Disease |
Q49960782 | Exosomal microRNA-21-5p Mediates Mesenchymal Stem Cell Paracrine Effects on Human Cardiac Tissue Contractility. |
Q91027293 | Exosomal non-coding RNAs (Exo-ncRNAs) in cardiovascular health |
Q38304096 | Exosome and its roles in cardiovascular diseases |
Q64246035 | Exosome in Cardiovascular Diseases: A Complex World Full of Hope |
Q99565623 | Exosome therapeutics for lung regenerative medicine |
Q47648689 | Exosomes Derived from Embryonic Stem Cells as Potential Treatment for Cardiovascular Diseases |
Q58796976 | Exosomes Derived from miR-214-Enriched Bone Marrow-Derived Mesenchymal Stem Cells Regulate Oxidative Damage in Cardiac Stem Cells by Targeting CaMKII |
Q39095686 | Exosomes Generated From iPSC-Derivatives: New Direction for Stem Cell Therapy in Human Heart Diseases |
Q26768620 | Exosomes Mediate the Intercellular Communication after Myocardial Infarction |
Q55083871 | Exosomes Secreted by Normoxic and Hypoxic Cardiosphere-derived Cells Have Anti-apoptotic Effect. |
Q26771909 | Exosomes and Their Therapeutic Potentials of Stem Cells |
Q50085056 | Exosomes and cardioprotection - A critical analysis |
Q36816939 | Exosomes and exosomal miRNAs in cardiovascular protection and repair. |
Q39301571 | Exosomes and their Application in Biomedical Field: Difficulties and Advantages. |
Q45974468 | Exosomes as agents of change in the cardiovascular system. |
Q42751931 | Exosomes as potential alternatives to stem cell therapy in mediating cardiac regeneration |
Q47732873 | Exosomes contribute to endothelial integrity and acute chest syndrome risk: Preliminary findings |
Q90168073 | Exosomes derived from cardiac progenitor cells attenuate CVB3-induced apoptosis via abrogating the proliferation of CVB3 and modulating the mTOR signaling pathways |
Q60953235 | Exosomes derived from cardiomyocytes promote cardiac fibrosis via myocyte-fibroblast cross-talk |
Q28081616 | Exosomes for Intramyocardial Intercellular Communication |
Q55261465 | Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. |
Q41001027 | Exosomes: A Rising Star in Falling Hearts |
Q33657616 | Exosomes: Fundamental Biology and Roles in Cardiovascular Physiology |
Q51083695 | Exosomes: What Do We Love So Much About Them? |
Q26797260 | Exosomes: emerging roles in communication between blood cells and vascular tissues during atherosclerosis |
Q39395324 | Exosomes: promising sacks for treating ischemic heart disease? |
Q37027245 | Exosomes: scytales in the damaged heart |
Q39166735 | Experimental, Systems, and Computational Approaches to Understanding the MicroRNA-Mediated Reparative Potential of Cardiac Progenitor Cell-Derived Exosomes From Pediatric Patients. |
Q40134679 | Extracellular Vesicle Biology in the Pathogenesis of Lung Disease |
Q89433754 | Extracellular Vesicles and the Application of System Biology and Computational Modeling in Cardiac Repair |
Q91656644 | Extracellular Vesicles in Cardiovascular Diseases: Alternative Biomarker Sources, Therapeutic Agents, and Drug Delivery Carriers |
Q91151804 | Extracellular vesicles from endothelial progenitor cells prevent steroid-induced osteoporosis by suppressing the ferroptotic pathway in mouse osteoblasts based on bioinformatics evidence |
Q94562484 | Extracellular vesicles from human embryonic stem cell-derived cardiovascular progenitor cells promote cardiac infarct healing through reducing cardiomyocyte death and promoting angiogenesis |
Q64287227 | Extracellular vesicles from regenerative human cardiac cells act as potent immune modulators by priming monocytes |
Q46268171 | Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology. |
Q47304481 | Extracellular vesicles, exosomes and shedding vesicles in regenerative medicine - a new paradigm for tissue repair. |
Q44870936 | Fabrication of Synthetic Mesenchymal Stem Cells for the Treatment of Acute Myocardial Infarction in Mice. |
Q36121826 | Fibroblasts Rendered Antifibrotic, Antiapoptotic, and Angiogenic by Priming With Cardiosphere-Derived Extracellular Membrane Vesicles |
Q33722094 | First Characterization of Human Amniotic Fluid Stem Cell Extracellular Vesicles as a Powerful Paracrine Tool Endowed with Regenerative Potential |
Q47763451 | Functional Role of Cardiovascular Exosomes in Myocardial Injury and Atherosclerosis |
Q90643310 | Human Cardiac Progenitor Cells Enhance Exosome Release and Promote Angiogenesis Under Physoxia |
Q99559581 | Hyperbaric oxygen-induced long non-coding RNA MALAT1 exosomes suppress MicroRNA-92a expression in a rat model of acute myocardial infarction |
Q64063282 | Identification of miRNA Reference Genes in Extracellular Vesicles from Adipose Derived Mesenchymal Stem Cells for Studying Osteoarthritis |
Q37667327 | Increased Circulating Exosomal miRNA-223 Is Associated with Acute Ischemic Stroke |
Q36180427 | Inhibiting Extracellular Vesicle Release from Human Cardiosphere Derived Cells with Lentiviral Knockdown of nSMase2 Differentially Effects Proliferation and Apoptosis in Cardiomyocytes, Fibroblasts and Endothelial Cells In Vitro. |
Q64968451 | Insights into Inflammatory Priming of Adipose-Derived Mesenchymal Stem Cells: Validation of Extracellular Vesicles-Embedded miRNA Reference Genes as A Crucial Step for Donor Selection. |
Q35890359 | Investigation of Content, Stoichiometry and Transfer of miRNA from Human Neural Stem Cell Line Derived Exosomes |
Q58226894 | Isolation and Characterization of Extracellular Vesicles in Stem Cell-Related Studies |
Q64277537 | Localized injection of miRNA-21-enriched extracellular vesicles effectively restores cardiac function after myocardial infarction |
Q90400720 | Message in a Bottle: Upgrading Cardiac Repair into Rejuvenation |
Q42651836 | MiR-145 facilitates proliferation and migration of endothelial progenitor cells and recanalization of arterial thrombosis in cerebral infarction mice via JNK signal pathway |
Q57115991 | MicroRNA-132, Delivered by Mesenchymal Stem Cell-Derived Exosomes, Promote Angiogenesis in Myocardial Infarction |
Q60056507 | Microvesicles and Exosomes in Local and Distant Communication with the Heart |
Q26770233 | Microvesicles and exosomes: new players in metabolic and cardiovascular disease |
Q41980044 | Mitochondrial pathways to cardiac recovery: TFAM. |
Q36550793 | More Than Tiny Sacks: Stem Cell Exosomes as Cell-Free Modality for Cardiac Repair |
Q48247352 | Myocardial Regeneration via Progenitor Cell-Derived Exosomes |
Q64950461 | Myocardial cell-to-cell communication via microRNAs. |
Q49991558 | Myocardial reparative functions of exosomes from mesenchymal stem cells are enhanced by hypoxia treatment of the cells via transferring microRNA-210 in an nSMase2-dependent way. |
Q96127279 | Native and bioengineered extracellular vesicles for cardiovascular therapeutics |
Q38804978 | New strategies for improving stem cell therapy in ischemic heart disease |
Q92823613 | Non-invasive characterization of human bone marrow stimulation and reconstitution by cell-free messenger RNA sequencing |
Q30360749 | Obstacles and opportunities in the functional analysis of extracellular vesicle RNA - an ISEV position paper |
Q33624309 | Overexpression of Exosomal Cardioprotective miRNAs Mitigates Hypoxia-Induced H9c2 Cells Apoptosis |
Q47200001 | Physiologic, Pathologic, and Therapeutic Paracrine Modulation of Cardiac Excitation-Contraction Coupling. |
Q59401908 | Polarized Secretion of Extracellular Vesicles by Mammary Epithelia |
Q89599353 | Potential Applications of Extracellular Vesicles in Solid Organ Transplantation |
Q37735796 | Potential Strategies to Address the Major Clinical Barriers Facing Stem Cell Regenerative Therapy for Cardiovascular Disease: A Review |
Q64085300 | Potential role of exosomes in the pathophysiology, diagnosis, and treatment of hypoxic diseases |
Q92443910 | Predicting Functional Responses of Progenitor Cell Exosome Potential with Computational Modeling |
Q38432905 | Pulmonary microRNA profiling: implications in upper lobe predominant lung disease. |
Q26777595 | Role and Function of MicroRNAs in Extracellular Vesicles in Cardiovascular Biology |
Q90307785 | Role of cardiac progenitor cell-derived exosome-mediated microRNA-210 in cardiovascular disease |
Q38543812 | Role of exosomes and microvesicles in hypoxia-associated tumour development and cardiovascular disease. |
Q38904719 | Roles of exosomes in cardioprotection |
Q90372519 | Stem Cell Therapies in Cardiovascular Disease |
Q39329517 | Stem Cell Therapy: A New Therapeutic Option for Cardiovascular Diseases. |
Q55071721 | Stem Cell-Derived Exosome in Cardiovascular Diseases: Macro Roles of Micro Particles. |
Q38997197 | Stem Cell-Derived Exosomes, Autophagy, Extracellular Matrix Turnover, and miRNAs in Cardiac Regeneration during Stem Cell Therapy |
Q58702281 | Stem cell-derived exosomes - an emerging tool for myocardial regeneration |
Q64078671 | Systems biology in inflammatory bowel diseases: on the way to precision medicine |
Q52647641 | Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide. |
Q57169628 | The Biological Mechanisms of Action of Cardiac Progenitor Cell Therapy |
Q26769042 | The Evolution of the Stem Cell Theory for Heart Failure |
Q55348000 | The Mingle-Mangle of Wnt Signaling and Extracellular Vesicles: Functional Implications for Heart Research. |
Q58771019 | The Potential of Stem Cells and Stem Cell-Derived Exosomes in Treating Cardiovascular Diseases |
Q50081195 | The Secret Life of Exosomes: What Bees Can Teach Us About Next-Generation Therapeutics |
Q60908823 | The Winding Road of Cardiac Regeneration-Stem Cell Omics in the Spotlight |
Q47852947 | Therapeutic angiogenesis of exosomes for ischemic stroke |
Q47108155 | Thy-1 dependent uptake of mesenchymal stem cell-derived extracellular vesicles blocks myofibroblastic differentiation. |
Q89686323 | Ticagrelor Enhances Release of Anti-Hypoxic Cardiac Progenitor Cell-Derived Exosomes Through Increasing Cell Proliferation In Vitro |
Q36922126 | Tiny Shuttles for Information Transfer: Exosomes in Cardiac Health and Disease |
Q90189747 | Vascular Smooth Muscle Cell-Derived Exosomal MicroRNAs Regulate Endothelial Cell Migration Under PDGF Stimulation |
Q42317706 | Vesicle miR-195 derived from Endothelial Cells Inhibits Expression of Serotonin Transporter in Vessel Smooth Muscle Cells |
Q37359807 | miR-21 Reduces Hydrogen Peroxide-Induced Apoptosis in c-kit+ Cardiac Stem Cells In Vitro through PTEN/PI3K/Akt Signaling. |
Q42135508 | miR-21 increases c-kit+ cardiac stem cell proliferation in vitro through PTEN/PI3K/Akt signaling |
Q26801614 | miRNA therapeutics in cardiovascular diseases: promises and problems |
Q38591803 | miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart |
Search more.